Julio Ramírez Selected Research

Julio Ramírez Research Topics

Disease

14	Rheumatoid Arthritis 05/2022 - 05/2012
10	Psoriatic Arthritis 01/2021 - 04/2012
6	Arthritis (Polyarthritis) 01/2022 - 01/2014
4	Inflammation (Inflammations) 07/2021 - 01/2014
4	Synovitis 12/2019 - 01/2014
3	Pain (Aches) 01/2022 - 07/2014
3	Palindromic rheumatism 12/2021 - 03/2015
2	COVID-19 01/2022 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 01/2019
2	Osteoporosis 10/2019 - 01/2018
2	Ankylosing Spondylitis 01/2014 - 08/2012
2	Rheumatic Diseases (Rheumatism) 01/2014 - 04/2011
1	Spondylitis 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Fever (Fevers) 12/2021
1	Pericarditis 12/2021
1	Abdominal Pain (Pain, Abdominal) 12/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Tenosynovitis 12/2019
1	Sleep Wake Disorders 11/2018
1	Infections 07/2018
1	Vitamin D Deficiency 01/2018
1	Edema (Dropsy) 12/2017
1	Tertiary Lymphoid Structures 07/2015
1	Tendinopathy (Tendonitis) 07/2014
1	Rotator Cuff Injuries 07/2014
1	Shoulder Pain 07/2014
1	Hyperpigmentation 08/2012
1	Localized Scleroderma (Morphea) 08/2012
1	Disease Progression 04/2011

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2013
4	AutoantibodiesIBA 05/2022 - 04/2012
4	AntibodiesIBA 01/2022 - 03/2015
4	CytokinesIBA 07/2015 - 04/2012
3	ametantrone (HAQ)IBA 01/2022 - 01/2022
3	Peptides (Polypeptides)IBA 01/2017 - 11/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 07/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 07/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2014 - 05/2012
1	Immunoglobulin G (IgG)IBA 01/2022
1	Rheumatoid FactorIBA 12/2021
1	Colchicine FDA LinkGeneric 12/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	amsonic acid (DAS)IBA 10/2020
1	Ustekinumab (CNTO 1275)FDA Link 10/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	N-phthaloylglutamic acidIBA 12/2019
1	C-Reactive ProteinIBA 12/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	Denosumab FDA Link 10/2019
1	GlycosaminoglycansIBA 01/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2018
1	Methotrexate (Mexate)FDA LinkGeneric 07/2018
1	SteroidsIBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2017
1	EpitopesIBA 01/2017
1	Interleukin-23 (Interleukin 23)IBA 07/2015
1	CC ChemokinesIBA 07/2015
1	LigandsIBA 07/2015
1	Interleukin-23 Subunit p19IBA 07/2015
1	CXC ChemokinesIBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 11/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Vascular Endothelial Growth Factor DIBA 01/2014
1	Angiopoietin-2IBA 01/2014
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2014
1	GlucocorticoidsIBA 01/2014
1	Biological ProductsIBA 01/2014
1	Tumor Necrosis Factor InhibitorsIBA 08/2012
1	Adalimumab (Humira)FDA Link 08/2012
1	Etanercept (Enbrel)FDA Link 05/2012
1	acetyl 4-aminosalicylic acidIBA 04/2011

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2011
2	Biological Therapy 01/2014 - 05/2012
1	Punctures 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Critical Care (Surgical Intensive Care) 11/2018
1	Drug Tapering 01/2014